Accordingly, the capacity of APP to modulate synaptic plasticity of GABAergic neurons [37] may indeed act in synergy with TNFα to affect neuronal excitability as previously reported at this stage of AD pathogenesis in APPswe/PS1dE9 mouse [21]. Here, APP is linked to Alzheimer disease.